Find clinical trials for Ovarian Cancer in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near San Francisco, CA, USA:
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...
Phase 2
San Francisco, California, United States and 25 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
San Francisco, California, United States and 125 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
San Francisco, California, United States and 213 other locations
be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...
Phase 1, Phase 2
Palo Alto, California, United States and 8 other locations
This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...
Phase 1
San Francisco, California, United States and 9 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Oakland, California, United States of America and 176 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
San Francisco, California, United States and 70 other locations
Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.
Phase 1
San Francisco, California, United States and 26 other locations
A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer...
Phase 2, Phase 3
Daly City, California, United States and 37 other locations
within each cohort-specific supplement in participants with ovarian, fallopian tube, or primary peritoneal cancer. Cohort A (single ...
Phase 1, Phase 2
San Francisco, California, United States and 24 other locations
Clinical trials
Research sites
Resources
Legal